S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 (2014/8/19)|
|Xencor Reports Third Quarter 2014 Financial Results|
|Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease (2014/10/28)|
|Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel|
|Xencor Provides Data Updates on XmAb Bispecific Antibody Programs and Announces Presentations at Upcoming American Society of Hematology 2014 Annual Meeting|
|Xencor to Present at the 2014 Credit Suisse Annual Healthcare Conference|
|Xencor to Host Third Quarter 2014 Financial Results Webcast and Conference Call|
|Rockwell announces another set of strong results for the second quarter with revenue up 71% and a corresponding decline in unit operating cash costs of 22% (2014/10/9)|
|RR Media Showcases Cloud-Based Online Video Dubbing Solution as Part of Global Media Services Platform|
|RRsat to Demonstrate Converged Broadcast & Online Video Service Solutions|
Click above to view more mutual fund data and stats for mor - MorphoSys AG.